Today we publish our five-year plan – ‘Improving health and wellbeing: Locally and globally 2014-2019’. The publication outlines our plans for the next five years to achieve continued excellence in research, education and patient care. It can be accessed on our website here.
Applications are now open for the Longitude Prize 2014. The Prize, which has a £10 million prize, has been launched to help solve one of the greatest problems of modern medicine – the rise of bacterial resistance to antibiotics.
Staff members from across King’s Health Partners have been recognised in the Health Service Journal’s ‘Top 50 BME Pioneers’ and ‘Top 50 Innovators’ lists:
The Community for Research Involvement and Support for People with Parkinson’s (CRISP) group has launched a new patient video project.
Only go to A&E when it is absolutely necessary – that is the key message of an eye-catching NHS winter campaign backed by King’s Health Partners.
To mark national Alcohol Awareness Week (17 – 23 November), King’s Health Partners is raising awareness about the pioneering projects in our Alcohol Strategy, which aims to reduce the burden of alcohol across our partner organisations and improve patient outcomes.
The report demonstrates the range and scale of the Charity’s work to improve the health and wellbeing of people living, working or being treated in Lambeth and Southwark.
Writing in the British Medical Journal(BMJ) this week, Addictions Clinical Academic Group (CAG) Leader Professor John Strang welcomed new World Health Organisation (WHO) guidance recommending that patients, families and others who may come into contact with heroin addicts should carry the drug naloxone, an antidote for opiate overdose.
South London and Maudsley (SLaM) is working with NHS England and a number of other health and social care organisations to ensure people in crisis get the best and most appropriate care.
Six leading figures from across King’s Health Partners were recognised in this year’s Health Service Journal (HSJ) Top 100 Clinical Leaders list.
A low-cost Breathlessness Support Service (BSS) led to a better quality of life and higher survival rates for patients with lung disease and cancer, according to a study by a team of researchers at King’s College London and clinicians from King’s College Hospital.